Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 2/5/20 (What's New)

Summary

    Prevention and Risk Reduction
    • Reduction in drug-use frequency and safer injection practices are more realistic goals than complete cessation for many people with substance use disorder until abstinence can be achieved
    • Provision of drug-use paraphernalia and education are essential HIV risk–prevention services for individuals with substance use disorder (Management Guidelines)[CDC Intervention]
    • PWIDs should be routinely screened for HBV, HCV, latent TB infection, syphilis, and other STDs, and offered pneumococcal, influenza, tetanus, and HBV immunization, and (when appropriate) prophylaxis for TB (Management Guidelines)[Aberg 2014]
    HIV Prevention

    Action required